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Mould Stachybotrys chartarum (Ehrenb.) Hughes is known to pose a health risk in indoor environments. 
Most of its strains can produce several intra- and extracellular trichothecene mycotoxins. Complex 
secondary metabolites of stachybotrys isolates from mouldy dwellings/public buildings in Slovakia were 
intratracheally instilled in Wistar male rats (4 µg in 0.2 mL of 0.2 % dimethylsulphoxide; diacetoxyscirpenol 
as the positive control). After three days, haematological parameters were measured in peripheral blood 
and infl ammatory response biomarkers in bronchoalveolar lavage fl uid (BALF), and the results were 
statistically analysed. Exometabolites proved to suppress red blood cell (RBC), decreasing the total RBC 
count, haemoglobin, and haematocrit. The exposed rats showed signifi cantly higher total BALF cell count, 
indicating infl ammation, lower alveolar macrophage counts, and increased granulocyte count related to the 
BALF cells. Due to haematotoxic and infl ammation-inducing properties, metabolites of S. chartarum can 
cause damage to the airways and haematological disorders in occupants of mouldy buildings.
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Indoor chemicals, viruses, bacteria (endotoxins of 
gram-negative in particular) or fungi can contribute 
to many so-called building-related illnesses, including 
allergic, infectious, toxic or infl ammatory diseases, 
and may even lead to precanceroses. A combination 
of symptoms and general discomfort associated with 
staying in certain buildings is known as the sick 
building syndrome (SBS) (1). The role of fungi in 
the aetiology of SBS has not yet been fully clarifi ed. 
Monitoring of exposure to indoor fungi is diffi cult 
because there are no standard methods to evaluate 
how indoor microclimate, outdoor ambient, and 
microscopic fungi affect each other. A general 
approach to studying how fungi affect humans 
*The subject was presented at the 2nd Croatian Scientifi c Symposium with 
International Participation Fungi and Mycotoxins – Health Aspects and 
Prevention, held in Zagreb, Croatia on 5 December 2008.
includes immunosuppressive effects of beta-glucans 
from the fungal cell wall and since recently the toxic 
and irritative effects of mycotoxins and/or volatile 
organic compounds (2). Mycotoxins which act through 
food or skin can produce similar adverse effects if 
inhaled at one tenth of the dose taken through food 
(3).
Although occupational pulmonary mycotoxicoses 
have been reported as a consequence of inhaled 
microbial toxins through organic dust (4), there 
has been no clinical evidence of their association 
with inhaled indoor mycotoxins. These are usually 
produced by Aspergillus spp., Penicillium spp., 
Fusarium spp., Trichoderma spp. and cellulolytic 
Stachybotrys chartarum (5). In the fatal infant 
idiopathic pulmonary haemorrhage outbreaks reported 
in the USA in the 1990’s, the moulds of S. chartarum 
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and Memnoniella echinata were isolated as possible 
culprits. Their toxic effects were confi rmed in vitro 
and in laboratory animals. S. chartarum produced 
macrocyclic trichothecenes (stachybotryotoxins) and 
spirocyclic drimanes; the fi rst were cytotoxic and 
immunosuppresive (in vitro) and the second caused 
infl ammation and haemorrhages in the respiratory 
tract and intestines of laboratory animals. M. echinata 
produced griseofulvins with a genotoxic potential 
(6). S. chartarum isolated from cardboard and vinyl 
ceilings of Scandinavian schools and dwellings 
produced the cytotoxic trichothecene trichodermol 
(7). Exo- and endometabolites of S. chartarum isolated 
from the mouldy walls of a house in Bratislava, 
Slovakia, induced a pulmonary injury in rats exposed 
intratracheally (8). Our previous study with tracheal 
organ cultures of one-day-old chicks showed varying 
ciliostatic activity of chloroform extracts of fungal 
biomass obtained from pure isolates of indoor moulds 
Penicillium chrysogenum, P. palitans, Trichoderma 
viride, Stachybotrys sp., and Aspergillus versicolor 
from building materials (mineral wool, plasterboard, 
cardboard). Generally, extracts from growths on 
materials composed of fi nely divided cellulose were 
more active than those taken from growths on mineral 
wool (9).
Toxic fungal metabolites are found in micromycetal 
propagules (endometabolites), aerosol, detritus, or 
house dust (exometabolites) (10). It is highly probable 
that hyphal fragments, dust and small particles of 
≤2 µm that can reach alveoli have the highest toxic 
potential. Most fungal spores do not get further than to 
the upper airways or bronchi at best, because of size, 
morphology, and the mode of propagation. This may 
be the reason why studies of the toxic effects of fungal 
spores do not refl ect real exposure (11-13).
The aim of this study was to establish the short-
term infl ammatory potential of S. chartarum in the 
respiratory tract of rats intratracheally exposed to its 
metabolites. The second aim was to establish their 
effects on peripheral blood of these animals.
METHODS
Fungal metabolites
S. chartarum was cultivated on a liquid medium 
with 2 % of yeast extract and 10 % sucrose at 25 °C 
for 10 days. The biomass (endometabolites) and the 
cultivation medium (exometabolites) were extracted 
separately with chloroform; extracts were dried under 
vacuum and dissolved in 0.2 % dimethylsulphoxide 
(DMSO; Merck, Darmstadt, Germany) to 20 µg mL-1 
(14).
Animal treatment and bronchoalveolar lavage
Groups of six male Wistar rats (Velaz, Prague, 
Czech Republic) weighing about 200 g (young 
adults) were exposed per toxicant. Animal treatment 
followed the Guidelines of the European Convention 
for the Protection of Vertebrate Animals for 
Experimental Purposes (15). Four micrograms of 
metabolite dissolved in 0.2 mL of 0.2 % DMSO were 
intratracheally instilled to each rat. Animals in the 
control group received 0.2 mL of 0.2 % DMSO alone. 
Mycotoxin diacetoxyscirpenol (DAS; Sigma, St. 
Louis, USA) was used as positive control. After 3-days 
of exposure, the animals were killed by exsanguination 
under thiopental anaesthesia (150 mg kg-1 b. w.) 
Bronchoalveolar lavage (BAL) was performed 
according to Myrvik et al. (16); the trachea was 
cannulated and the lungs washed with 5 mL of saline 
in situ fi ve times. The pooled bronchoalveolar lavage 
fluid (BALF) was centrifuged (450 g at 4 °C for 
10 min), and BALF cells isolated (17). Lung proteins 
were measured with Folin’s phenol reagent according 
to Lowry et al. (18).
Infl ammatory response biomarkers
Parameters indicating lung tissue infl ammation 
included total BALF cell count and alveolar 
macrophage (AM) count (both determined in the 
Bürker’s chamber), AM to total cell ratio, monocyte 
count, binucleate cell count, and polymorphonucleate 
(PMN) cell count. All preparations were stained with 
May-Grünwald-Giemsa stain (17).
The phagocytic activity of AM was determined 
according to Fornůsek et al. (19), using 2-
hydroxyethylmetacrylate particles (HEMA; Neosys, 
Prague, Czech Republic). Fifty millilitres of HEMA 
particles in phosphate buffered saline (PBS), pH 7.2, 
were added to 100 mL of BALF and incubated at 
37 °C for 60 min and shaken at short intervals. After 
May-Grünwald-Giemsa staining, the cells which 
phagocytised at least three particles were considered 
positive.
AM viability was established by fluorescent 
microscopy of slides stained with 1 mL of 0.25 % 
erythrosine per 1 mL of cell suspension (density 1x106 
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cells mL-1). Viable cells were counted in the Bürker’s 
chamber (18). The results were statistically evaluated 
using the Mann-Whitney U test.
Evaluation of haematotoxicity
Before killing the animals, we collected fresh 
peripheral blood samples by venipuncture into 
heparinised vacutainers. For blood analysis, we used 
fully automated haematology analyser Sysmex K-
4500 (Sysmex Toa Medial Electronics Co., Japan). 
The analysis included red and white blood cell 
count, platelet count, haemoglobin, hematocrit, mean 
corpuscular volume, and lymphocyte and neutrophil 
percentage. Data were statistically evaluated using 
Student’s t-test.
RESULTS AND DISCUSSION
Infl ammatory activity of S. chartarum metabolites in 
animal lungs
Intratracheal instillation is a common method to 
study toxic effects of different substrates in animals 
in vivo. Bronchoalveolar lavage (BAL) is the best 
and quickest tool to screen for pulmonary toxicants, 
especially complex mixtures, even if their chemical 
structure is unknown. The method makes it possible 
to quantify markers of infl ammatory and/or cytotoxic 
response. BAL is more sensitive than histological 
examination, and is also used in the diagnostics of 
pulmonary diseases (20, 21).
We selected day 3 of exposure to measure our 
infl ammation and haematotoxicity parameters because 
earlier studies of in vitro (22, 23) and in vivo (8, 13) 
toxicity of S. chartarum have shown that metabolite/
spore activity drops below the detection limit after the 
third day, as recovery starts to take over.
Rat autopsy in our experiment showed no changes 
in the relative lung mass (average 9.3x10-3 kg to 
10.2x10-3 kg). Neither was the increase in total 
proteins in cell-free BALF statistically signifi cant 
(Table 1). The most common protein in BALF was 
albumin. Its increase is considered to be an early 
indicator of inflammation, but it can also reflect 
porcine pulmonary oedema, and can be affected by the 
age and a chronic disease (5, 24). Unlike us, Rao et al. 
found signifi cantly elevated albumin concentrations in 
BALF (13) as an early effect of S. chartarum spores 
on rodent lungs.
Toxicants in the lungs can cause several immediate 
reactions of the epithelial cells, including type II (T2) 
lung cells, such as increase in capillary permeability, 
white blood cell chemotaxis and extravasation into 
BALF, or fi brin deposition in the surrounding area. 
Kováčiková et al. observed concentration-dependent 
fragmentation of the T2 cell membrane exposed to S. 
chartarum metabolites (23). In this experiment, the 
total infl ammatory cell count in BALF signifi cantly 
increased after treatment with DAS, endometabolites, 
and exometabolites compared to DMSO (Figure 1).
Table 1  Changes in lung weight and protein content in rats caused by S. chartarum exometabolites, endometabolites, 










BALF – bronchoalveolar lavage fl uid
Values represent medians and standard deviations.
Figure 1  Total cell count in bronchoalveolar lavage fl uid 
(BALF) after exposure to carrier dimethysulphoxide 
(DMSO), endo- and exometabolites of S. chartarum, 
or diacetoxyscirpenol standard (DAS)
Values represent medians and 25th and 75th 














Piecková E, et al. INFLAMMATORY AND HEMATOTOXIC POTENTIAL OF INDOOR STACHYBOTRYS CHARTARUM
Arh Hig Rada Toksikol 2009;60:401-409
404
AMs as cells of the fi rst defence line have not only 
phagocytic, but also immunoregulatory properties. 
In addition, AMs play an important part in the 
infl ammatory reaction; they stimulate infl ammatory 
cells to secrete various cytokines, growth factors, and 
pro-infl ammatory mediators. Changes in macrophage 
count or function can infl uence the lung injury and 
defi ne the course of the disease. Lower macrophage 
count or phagocytic capacity may result in lower 
clearance of inhaled toxicants and thus in elevated 
effective dose. On the other hand, higher AM count 
may also increase the release of proteases, reactive 
oxygen species, and fi broblast-regulating mediators, 
which adversely affect the lung (25).
In our experiment, the number of AM in BALF 
was signifi cantly lower in rats treated with DAS 
(p<0.05) and stachybotrys exometabolites (p<0.01) 
than with DMSO (Figure 2); this supports another 
study of the toxic effects of stachybotrys spores in 
rats (13). In normal rodent BALF, AMs account 
for more than 95 % of all white blood cells. Quite 
remarkably, the proportion of AMs in total BALF 
cells remained unchanged in our study (Figure 3). 
However, the significantly increased proportion 
of young AMs, which are an immature form of 
macrophages, in rats treated with exometabolites 
and DAS (both p<0.01) (Figure 4) suggest that they 
have replaced a number of mature AMs. The same 
may be true for polymorphonuclear cells (PMN), 
whose proportion also increased with DAS and all 
metabolite treatment, even though the increase was 
not statistically signifi cant (Figure 5). Immature cells 
usually occur after exposure to inorganic dusts or due 
to an interstitial lung disease such as sarcoidosis (26). 
The signifi cant increase in young AM proportion is 
probably related to signifi cantly lower AM viability, 
which is either a secondary effect of infl ammation 
or the consequence of mycotoxin cytotoxicity (27) 
(Figure 6).
AM phagocytic activity was not significantly 
affected by any of the toxicants used (Figure 7). 
This does not come as surprise because the toxicants 
were not particulate, and therefore did not induce 
phagocytosis.
PMNs form the second line of defence; they act 
as phagocytes and release vasodilators important in 
infl ammation. Normally, they constitute less than 
2 % of rodent BAL cells, but in acute infl ammation 
their proportion may rise to over 90 %. PMNs are 
attracted to the lungs by chemokines secreted mostly 
Figure 2  Alveolar macrophage (AM) count in bronchoalveolar 
lavage fluid (BALF) after exposure to carrier 
dimethysulphoxide (DMSO), endo- and exometabolites 
of S. chartarum, or diacetoxyscirpenol standard 
(DAS)
Values represent medians and 25th and 75th 
percentiles.
* p< 0.05; ** p< 0.01
Figure 3  Proportion of alveolar macrophages (AM; % of total 
cells) in bronchoalveolar lavage fl uid (BALF) after 
exposure to carrier dimethysulphoxide (DMSO), 
endo- and exometabolites of S. chartarum, or 
diacetoxyscirpenol standard (DAS) 
Values represent medians and 25th and 75th 
percentiles.
Figure 4  Proportion of monocytes (immature alveolar 
macrophages; % of total cells) in bronchoalveolar 
lavage fluid (BALF) after exposure to carrier 
dimethysulphoxide (DMSO), endo- and exometabolites 
of S. chartarum, or diacetoxyscirpenol standard 
(DAS)
Values represent medians and 25th and 75th 
percentiles.
** p< 0.01
by AMs. If high levels persist for long, this may 
indicate a precancer (28). In our experiment, DAS 
and all stachybotrys metabolites increased the PMN 
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signifi cant in respect to DMSO (Figure 5). A similar 
PMN elevation was described in rats intratracheally 
exposed to fungal spores (13).
Binucleate cells (BNC) constitute about 1 % 
of a normal human lung tissue suspension and are 
often found in BALF. Their number may rise after 
long-term exposure to genotoxicants such as tobacco 
smoke, chemicals) (29-32) or certain dusts (33, 34). 
BNC and multinucleate cell (MNC) counts in lung 
suspension may well refl ect chronic infl ammation, and 
may serve as good semi-quantitative biomarkers (35). 
In our study, BNC proportion in BALF increased to 
almost 2 % in the rats exposed to exometabolites and 
DAS. However, these changes were not signifi cant 
because the experiment took only three days and the 
infl ammation was still acute (Figure 8).
Commercial ly  avai lable  Fusarium  spp. 
trichothecene mycotoxin DAS can cause infl ammation 
and haemorrhage similar to the one caused by 
stachybotrys toxicants (37). The exometabolites of S. 
chartarum used in our experiments showed stronger 
infl ammatory potential than endometabolites (Tables 
2 and 3).
Figure 5  Proportion of polymorphonuclear cells (PMN; 
% total cells) in bronchoalveolar lavage fluid 
(BALF) after exposure to carrier dimethysulphoxide 
(DMSO), endo- and exometabolites of S. chartarum, 
or diacetoxyscirpenol standard (DAS) 
Values represent medians and 25th and 75th 
percentiles. 
Figure 6  Viability of alveolar macrophages (AM; % of living 
cells) after exposure to carrier dimethysulphoxide 
(DMSO), endo- and exometabolites of S. chartarum, 
or diacetoxyscirpenol standard (DAS))
Values represent medians and 25th and 75th 
percentiles. 
* p< 0.05; ** p< 0.01
Figure 7  Phagocytic activity of alveolar macrophages 
(AM; % of phagocytic cells) after exposure to 
carrier dimethysulphoxide (DMSO), endo- and 
exometabolites of S. chartarum, or diacetoxyscirpenol 
standard(DAS) 
Values represent medians and 25th and 75th 
percentiles.
* p< 0.05; ** p< 0.01
Figure 8  Proportion of binucleate cells (% of total cells) 
in bronchoalveolar lavage fluid (BALF) after 
exposure to carrier dimethysulphoxide (DMSO), 
endo- and exometabolites of S. chartarum, or 
diacetoxyscirpenol standard (DAS)
Values represent medians and 25th and 75th 
percentiles.
Table 2  Comparison between groups exposed to S. chartarum 
endometabolites, and exometabolites
Infl ammation biomarkers
BALF cell count n
AM count in BALF **↑
Proportion of AM in BALF n
Proportion of PMN cells in BALF n
Proportion of young monocytic AM forms 
in BALF
*↓
Proportion of binucleate cells in BALF n
Viability of AM (% of living cells) n
Phagocytic activity of AM (% of phagocytic 
cells)
n
BALF – bronchoalveolar lavage fluid; AM – alveolar 
macrophage; PMN – polymorphonuclear cells
*p< 0.05; **p<0.01; ↑ - increase against the compared group; 
↓ - decrease against the compared group; 
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Table 3  Comparison between groups exposed to S. 







BALF cell count n n
AM count in BALF *↑ n
Proportion of AM in 
BALF
n n
Proportion of PMN cells 
in BALF
n n
Proportion of young 
monocytiyc AM forms in 
BALF
n n
Proportion of binucleate 
cells in BALF
n n
Viability of AM (% of 
living cells)
n n
Phagocytic activity of AM 
(% of phagocytic cells)
*↑ n
BALF – bronchoalveolar lavage fluid; AM – alveolar 
macrophage; PMN – polymorphonuclear cells
*p< 0.05; ↑- increase against the compared group
n – no signifi cant change; 
Haematotoxicity of S. chartarum metabolites
Rats exposed to stachybotrys exometabolites 
showed a statistically signifi cant drop in RBC count 
(p<0.01), and in haemoglobin and hematocrit levels 
(p<0.05) (Figures 9 - 11). No signifi cant changes were 
found in other haematological parameters in exposed 
rats. Our findings confirm reports in veterinary 
medicine, on equine stachybotryotoxicosis in 
particular (5). S. chartarum synthesises a haemolytic 
agent stachylysin, which lowers haemoglobin 
concentration, and some siderophore compounds 
which lower hematocrit. Stachylysin is produced by 
all strains of the fungus tested so far and is essentially 
specifi c to the species. It is highly immunogenic. Some 
scientists suggest that some fl u-like and/or cold-like 
SBS symptoms in humans are caused by fungal 
haemolysins which activate histamine and cytokine 
producing cells. The effect of fungal haemolysins on 
the vascular tissue may in turn cause other symptoms 
such as headache, dizziness, and bleeding (37).
CONCLUSIONS
Our study has demonstrated the damaging 
potential of indoor S. chartarum metabolites to 
Figure 11  Hematocrit in peripheral blood of rats exposed 
to carrier dimethysulphoxide (DMSO), endo- 
and exometaboli tes of  S.  chartarum, or 
diacetoxyscirpenol standard (DAS)
Values represent means and standard deviations.
* p< 0.05
Figure 9  Red blood cells (RBC) count in peripheral blood of 
rats exposed to carrier dimethysulphoxide (DMSO), 
endo- and exometabolites of S. chartarum, or 
diacetoxyscirpenol standard (DAS)
Values represent means and standard deviations. 
** p< 0.01.
Figure 10  Haemoglobin concentration in peripheral blood of 
rats exposed to carrier dimethysulphoxide (DMSO), 
endo- and exometabolites of S. chartarum, or 
diacetoxyscirpenol standard (DAS)
Values represent means and standard deviations.
* p< 0.05
rodent lungs through infl ammation and haematotoxic 
action. The toxicity was more pronounced with 
extracellular metabolites, which suggests that 
exotoxins cause greater adverse effects than fungal 
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exposure to moulds in buildings are still inexact, their 
toxic potential should not be neglected. Future risk 
assessment studies should seek to assess exposure 
to indoor fungal toxins with as much precision as 
possible, especially to their real mixtures. Estimations 
should also include confounding factors such as 
endotoxins, chemicals, stress, and diet. Furthermore, 
knowledge of the dose-effect relationships and of 
fungal deposition in the lungs could help to better 
understand fungal contribution to the sick building 
syndrome.
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Sažetak
UPALNI I HEMATOTOKSIČNI POTENCIJAL METABOLITA PLIJESNI STACHYBOTRYS 
CHARTARUM (EHRENB.) HUGHES U ZATVORENIM PROSTORIJAMA
Plijesan Stachybotrys chartarum (Ehrenb.) Hughes poznata je kao rizični mikroorganizam u zatvorenim 
prostorijama. Većina njezinih sojeva može proizvesti nekoliko unutarstaničnih i izvanstaničnih 
trikotecenskih mikotoksina. Muškim Wistar štakorima instilirani su intratrahealno kompleksni sekundarni 
metaboliti stahibotrisa izolirani iz stambenih i javnih zgrada u Slovačkoj zahvaćenima plijesni (4 µg 
na 0,2 mL 0,2 %-tnog dimetilsulfoksida; dok se diacetoksiscirpenol rabio kao pozitivna kontrola). Tri 
dana kasnije izmjereni su hematološki parametri u perifernoj krvi te biopokazatelji upalnoga odgovora u 
bronhoalveolarnome ispirku te su rezultati obrađeni statistički. Pokazalo se da egzometaboliti suprimiraju 
eritrocite, smanjujući njihov ukupni broj, hemoglobin i hematokrit. Izloženi štakori imali su značajno veći 
broj stanica u bronhoalveolarnome ispirku, što upućuje na upalu, dok im je broj alveolarnih makrofaga bio 
manji, a broj granulocita povezanih sa stanicama u ispirku veći. Zbog svojih hematotoksičnih i upalnih 
svojstava S. chartarum može dovesti do oštećenja dišnih putova i poremećaja u krvotvornome sustavu 
osoba koje žive i/ili rade u zgradama zahvaćenima tom plijesni.
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